Johnson MA - Search Results

1

Prospective association of social circumstance, socioeconomic, lifestyle and mental health factors with subsequent hospitalisation over 6-7 year follow up in people living with HIV.

Rein SM, Smith CJ, Chaloner C, Stafford A, Rodger AJ, Johnson MA, McDonnell J, Burns F, Madge S, Miners A, Sherr L, Collins S, Speakman A, Phillips AN, Lampe FC. Rein SM, et al. Among authors: johnson ma. EClinicalMedicine. 2020 Dec 1;31:100665. doi: 10.1016/j.eclinm.2020.100665. eCollection 2021 Jan. EClinicalMedicine. 2020. PMID: 33554077 Free PMC article.

2

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.

Matthews GV, Sabin CA, Mandalia S, Lampe F, Phillips AN, Nelson MR, Bower M, Johnson MA, Gazzard BG. Matthews GV, et al. Among authors: johnson ma. AIDS. 2002 Jan 4;16(1):53-61. doi: 10.1097/00002030-200201040-00008. AIDS. 2002. PMID: 11741163 Clinical Trial.

3

Brief report: two-year outcome of a multidrug regimen in patients who did not respond to a protease inhibitor regimen.

Youle M, Tyrer M, Fisher M, Lampe F, Wilson D, Ransom D, Story A, Mocroft A, Loveday C, Johnson MA, Phillips AN. Youle M, et al. Among authors: johnson ma. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):58-61. doi: 10.1097/00126334-200201010-00008. J Acquir Immune Defic Syndr. 2002. PMID: 11782591 Clinical Trial.

4

Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study.

Moore AL, Sabin CA, Johnson MA, Phillips AN. Moore AL, et al. Among authors: johnson ma. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):197-202. doi: 10.1097/00042560-200202010-00015. J Acquir Immune Defic Syndr. 2002. PMID: 11832692

5

Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?

Moore AL, Youle M, Lipman M, Cozzi-Lepri A, Lampe F, Madge S, Nesaratnam S, Tyrer M, Cuthbertson Z, Ransom D, Loveday C, Johnson MA, Phillips AN; Royal Free Centre for HIV Medicine. Moore AL, et al. Among authors: johnson ma. AIDS. 2002 Mar 8;16(4):615-8. doi: 10.1097/00002030-200203080-00013. AIDS. 2002. PMID: 11873005

6

Highly active antiretroviral therapy and cervical intraepithelial neoplasia.

Moore AL, Sabin CA, Madge S, Mocroft A, Reid W, Johnson MA. Moore AL, et al. Among authors: johnson ma. AIDS. 2002 Apr 12;16(6):927-9. doi: 10.1097/00002030-200204120-00014. AIDS. 2002. PMID: 11919496

7

Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression.

Phillips AN, Staszewski S, Lampe F, Youle MS, Klauke S, Bickel M, Sabin CA, Doerr HW, Johnson MA, Loveday C, Miller V; Royal Free Centre for HIV Medicine; Goethe Universität Clinic Cohort. Phillips AN, et al. Among authors: johnson ma. J Infect Dis. 2002 Oct 15;186(8):1086-91. doi: 10.1086/343801. Epub 2002 Sep 30. J Infect Dis. 2002. PMID: 12355358 Free article.

8

Viral breakthrough after suppression with highly active antiretroviral therapy: experience from 233 individuals with viral loads of less than 50 copies/ml followed for up to 4 years.

Lampe FC, Johnson MA, Lipman M, Loveday C, Youle M, Ransom D, Sabin CA, Tyrer M, Phillips AN. Lampe FC, et al. Among authors: johnson ma. AIDS. 2003 Mar 28;17(5):768-70. doi: 10.1097/01.aids.0000050876.71999.11. AIDS. 2003. PMID: 12646806 No abstract available.

9

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy.

Smith CJ, Sabin CA, Lampe FC, Kinloch-de-Loes S, Gumley H, Carroll A, Prinz B, Youle M, Johnson MA, Phillips AN. Smith CJ, et al. Among authors: johnson ma. AIDS. 2003 May 2;17(7):963-9. doi: 10.1097/00002030-200305020-00004. AIDS. 2003. PMID: 12700445

10

Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individuals.

Smith CJ, Staszewski S, Sabin CA, Nelson M, Dauer B, Gute P, Johnson MA, Phillips AN, Gazzard B. Smith CJ, et al. Among authors: johnson ma. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1155-9. doi: 10.1097/01.qai.0000135958.80919.e4. J Acquir Immune Defic Syndr. 2004. PMID: 15319675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,674 results

Search Page